Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

Monica Hazra, Hiroyuki Uchida, Beth Sproule, Gary Remington, Takefumi Suzuki, David C. Mamo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

Original languageEnglish
Pages (from-to)676-678
Number of pages3
JournalPsychiatry and Clinical Neurosciences
Volume65
Issue number7
DOIs
Publication statusPublished - 2011 Dec

Fingerprint

Polypharmacy
Pharmacists
Antipsychotic Agents
Schizophrenia
Prescriptions
Canada
Inpatients
Mental Health
Outpatients
Physicians
Education

Keywords

  • antipsychotic
  • monitoring
  • polypharmacy
  • prescription
  • schizophrenia

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. / Hazra, Monica; Uchida, Hiroyuki; Sproule, Beth; Remington, Gary; Suzuki, Takefumi; Mamo, David C.

In: Psychiatry and Clinical Neurosciences, Vol. 65, No. 7, 12.2011, p. 676-678.

Research output: Contribution to journalArticle

Hazra, Monica ; Uchida, Hiroyuki ; Sproule, Beth ; Remington, Gary ; Suzuki, Takefumi ; Mamo, David C. / Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. In: Psychiatry and Clinical Neurosciences. 2011 ; Vol. 65, No. 7. pp. 676-678.
@article{232d0f60759d470ba4914b06caa2901b,
title = "Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia",
abstract = "The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3{\%}) and 2008 (6.6{\%}). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.",
keywords = "antipsychotic, monitoring, polypharmacy, prescription, schizophrenia",
author = "Monica Hazra and Hiroyuki Uchida and Beth Sproule and Gary Remington and Takefumi Suzuki and Mamo, {David C.}",
year = "2011",
month = "12",
doi = "10.1111/j.1440-1819.2011.02280.x",
language = "English",
volume = "65",
pages = "676--678",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

AU - Hazra, Monica

AU - Uchida, Hiroyuki

AU - Sproule, Beth

AU - Remington, Gary

AU - Suzuki, Takefumi

AU - Mamo, David C.

PY - 2011/12

Y1 - 2011/12

N2 - The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

AB - The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

KW - antipsychotic

KW - monitoring

KW - polypharmacy

KW - prescription

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84255190969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255190969&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2011.02280.x

DO - 10.1111/j.1440-1819.2011.02280.x

M3 - Article

VL - 65

SP - 676

EP - 678

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 7

ER -